Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Assets Average (2016 - 2025)

iBio (IBIO) has disclosed Assets Average for 15 consecutive years, with $64.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average rose 178.16% to $64.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $64.3 million, a 178.16% increase, with the full-year FY2025 number at $26.0 million, down 25.77% from a year prior.
  • Assets Average was $64.3 million for Q4 2025 at iBio, up from $43.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $145.4 million in Q3 2021 to a low of $20.4 million in Q1 2025.
  • A 5-year average of $70.2 million and a median of $45.9 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 266.52% in 2021, then crashed 60.22% in 2023.
  • iBio's Assets Average stood at $135.1 million in 2021, then plummeted by 49.53% to $68.2 million in 2022, then crashed by 47.42% to $35.8 million in 2023, then plummeted by 35.55% to $23.1 million in 2024, then surged by 178.16% to $64.3 million in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Assets Average are $64.3 million (Q4 2025), $43.7 million (Q3 2025), and $21.1 million (Q2 2025).